Over 170,000 Bottles of Apple Juice Recalled Nationwide—Here's What to Know
Martinelli apple juice is being recalled.
The 10-ounce bottles of apple juice were sold in 4-packs in 28 states.
The recall is due to a potential contamination of the mycotoxin patulin.A recall on a popular brand of apple juice sold in 28 states was just announced, according to the U.S. Food & Drug Administration (FDA). This is due to a potential contamination with patulin, a mycotoxin that can cause internal organ damage when consumed in excess. Approximately 173,616 bottles are affected by this recall.
The product impacted is Martinelli Apple Juice sold in its signature clear, round glass bottles with a white metal screw top lid. The recalled 10-ounce apple juice bottles were sold in 4-packs, contain a UPC of '0 41244 04102 2' and have a best-by date of December 5, 2026. They were sold at retail locations in the following states: Alabama, Arkansas, Arizona, California, Connecticut, Delaware, Florida, Georgia, Iowa, Illinois, Indiana, Kansas, Kentucky, Louisiana, Michigan, Missouri, Mississippi, North Carolina, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, South Carolina, Texas, Utah, Virginia and Wisconsin.
This recall was just classified as a Class II recall, meaning that drinking this apple juice can 'cause temporary or medically reversible adverse health consequences,' per the FDA. Patulin is a toxic substance produced by molds that can grow on apples, so it is sometimes found in apple juice products, leading to contamination. If you are experiencing any signs of illness after consuming the recalled apple juice, talk to your healthcare provider immediately.
For questions about this recall, contact the FDA by calling 1-888-INFO-FDA (1-888-463-6332).
Related: Aldi Just Issued a Health Alert on a Pork Product Nationwide Due to Contamination
Read the original article on EATINGWELL
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
28 minutes ago
- USA Today
Was the potentially radioactive shrimp sold in your state? See map.
A recall has been issued for frozen shrimp sold at Walmart in 13 states that may have been contaminated with a radioactive chemical, the Food and Drug Administration said. On Tuesday, Aug. 19, the FDA advised the recall after it detected Cesium-137 (Cs-137), a radioactive chemical "produced by nuclear fission for use in medical devices and gauges," according to the Environmental Protection Agency. The chemical was detected in four U.S. ports across the country and in a sample of breaded shrimp, the FDA stated. "Although testing to date has not confirmed the presence of contamination in any product in commerce, the product appears to have been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with Cs-137 and may pose a safety concern," the FDA advised. The FDA is investigating the situation. Which states sold the recalled frozen shrimp? The recalled shrimp were sold in the following 13 states: More recalls: Over 78,000 Jeep Wrangler vehicles recalled. Here's why. Ports that received contaminated shipping containers The four ports where the FDA detected contaminated shipping containers are in the following cities: Which products were recalled? The recall is targeted at 2-pound bags of Great Value brand Frozen Raw Ez Peel Tail-On Farm-Raised White Vannamei Shrimp. Lot codes and best by dates include the following: The shrimp products are processed by PT. Bahari Makmur Sejati, a company in Indonesia doing business as BMS Foods, according to the FDA. What to do if you have recalled shrimp If you have a package of the recalled Walmart shrimp at home, throw it away and do not eat or serve it, the FDA notice says. Distributors and retailers should dispose of the product and refrain from selling it. Anybody who fears they may have been exposed to elevated levels of cesium should contact their medical providers. To submit a complaint or report an adverse reaction, consumers can visit the FDA's Industry and Consumer Assistance portal. PT. Bahari Makmur Sejati placed under an import alert PT. Bahari Makmur Sejati has also been placed on an import alert for chemical contamination, which prevents any of the company's food products from entering the United States until it resolves any conditions that could have caused the exposure. The FDA is working with Indonesian seafood regulatory authorities to investigate the cause of the contamination. What is Cesium-137 (Cs-137) and why is it regulated? Cs-137 is a radioisotope of cesium, meaning it is a chemical element that emits radiation as it breaks down. It is man-made and is produced by nuclear fission, according to the FDA. In the United States, it is used in medical devices and measurement gauges, such as industrial devices that measure the thickness of materials. "It is also one of the byproducts of nuclear fission processes in nuclear reactors and nuclear weapons testing," the EPA stated. Because it is widespread around the globe, trace amounts can be found in the environment, including in soil, food and air, the FDA. Agencies, including the FDA and U.S. Customs & Border Protection, test for, monitor and regulate the presence of the substance due to the risks associated with long-term exposure. Low-level radiation exposure over time can lead to serious health complications, the FDA said. Exposure to Cs-137 alone can cause burns, acute radiation sickness, cancer and death. As a result, the governing agencies restrict potential exposure to lessen the possibility of these long-term impacts. Julia is a trending reporter for USA TODAY. Connect with her on LinkedIn, X, Instagram and TikTok: @juliamariegz, or email her at jgomez@
Business Wire
an hour ago
- Business Wire
Verantos to Present Practical Approaches in High-Validity Real-World Evidence Generation at ISPE's 41st Annual Meeting
MENLO PARK, Calif.--(BUSINESS WIRE)-- Verantos, the global leader in high-validity real-world evidence at scale, announced today that it will present practical approaches for generating high-validity real-world evidence (RWE) at the International Society for Pharmacoepidemiology (ISPE) 41st Annual Meeting in Washington, D.C. The goal isn't just to measure data reliability; it's to optimize it and to do so using peer-reviewed, published methods so metrics can't be gamed. Share CEO Dan Riskin will share approaches to achieve fit-for-use RWD based on real-world learnings from large pharma collaborations and the FDA-sponsored Verantos-led TRUST and VERIFY studies. He will discuss 'Data reliability: implementing accuracy, completeness, and traceability in practice.' 'The goal isn't just to measure data reliability; it's to optimize it and to do so using peer-reviewed, published methods so metrics can't be gamed,' said Riskin. 'Evidence generated using low-quality or untested RWD remains suspect as it always has been.' Symposium snapshot ISPE 41st Annual Meeting, Washington, D.C. Real-world evidence fit for regulatory applications — what does good look like? Tuesday, August 26, 10:30am EDT Verantos will detail practical implementation approaches to quantify and improve accuracy, completeness, and traceability consistent with peer-reviewed methods and learnings from the TRUST and VERIFY studies. Early findings from this work have been published in JAMA Network Open, providing a transparent foundation for reliability measurement and optimization. About Verantos Verantos is the global leader in high-validity real-world evidence for life sciences organizations. By incorporating robust clinical narrative data and artificial intelligence technology, Verantos is the first company to generate high-validity evidence at scale across therapeutic areas with measured accuracy, completeness, and traceability. Credible evidence accelerates clinical development, market access, medical affairs, pharmacovigilance, and regulatory initiatives.
Newsweek
an hour ago
- Newsweek
7Up Recalled Issued After Sugar Mix Up in Thousands of Cans
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A voluntary recall has been issued for nearly 2,000 cases of 7Up Zero Sugar Tropical Soda sold in Alabama, Florida and Georgia after it was discovered that some cans labeled "Zero Sugar" actually contain sugar. The recall, initiated on July 31, 2025, by Buffalo Rock Company Inc., is classified as Class II by the U.S. Food and Drug Administration (FDA), meaning exposure to the mislabeled product may cause temporary or medically reversible health consequences but is unlikely to lead to serious adverse health effects. Newsweek reached out to Buffalo Rock for comment via an online form on the company's website. Newsweek also contacted Keurig Dr Pepper, the manufacturer of 7Up, for comment via email. Why It Matters Consumers with dietary restrictions related to sugar intake, such as those managing diabetes, may unknowingly ingest sugar if they consume the mislabeled soda. The health implications can be serious for those relying on accurate nutritional labeling to maintain blood glucose levels or manage metabolic conditions. Newsweek What To Know The product in question is sold in 12-pack cartons labeled "7up Tropical Flavored Soda." The aluminum cans themselves are marked "7UP Zero Sugar Tropical Soda" with a UPC code of 078000037975, while the carton bears UPC code 078000037982. The affected lot numbers are XXXXBR062156 and XXXXBR062256, with a use-by date of MAR 23 26. Buffalo Rock, a beverage bottling and distribution company based in Birmingham, Alabama, did not issue a public press release for the recall but notified distributors through multiple methods, including email, fax, phone, letters, and direct visits. FDA inspectors carry out a hazard assessment before issuing one of three risk levels. The three classifications are these: Class I —a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death. —a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death. Class II —a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. —a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. Class III—a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences. What People Are Saying The FDA said on its website: "Product problems should be reported to the FDA when there is a concern about the quality, authenticity, performance, or safety of any medication or device. Problems with product quality may occur during manufacturing, shipping, or storage. They include ... labeling concerns."
